Beijing, April 18, 2024 - Singclean Medical was awarded the title of national-level specialized and new "Little Giant" enterprise. This honor commends Singclean Medical for its professionalism, innovation, production strength, and product uniqueness in the medical field. contribute.
As a leading company focusing on the field of medical devices, Singclean Medical has established a good reputation in the industry for its excellent professionalism. The company has a high-quality R&D team that is constantly committed to innovation and breakthroughs in medical technology. Through cooperation with top domestic and foreign scientific research institutions, Singclean Medical has achieved a series of important results in the field of medical devices and biological products, injecting new vitality into the development of the industry.
In terms of product innovation, Singclean Medical has always adhered to the concept of "market demand as the guide and technological innovation as the driving force" and continuously launched high-quality products that meet clinical needs. Its products cover many fields, including biomedical sodium hyaluronate gel, tissue engineering, etc., among which there are many domestically leading and international-level technical products. These products are not only highly recognized in the domestic market, but also sold overseas, winning a wide range of international markets.
Singclean Medical has advanced production equipment and a strict quality management system to ensure product quality and stability. The company always adheres to the principle of "quality first, service first" to provide customers with high-quality products and professional services.
Winning the title of "Little Giant" enterprise is an affirmation and encouragement for Singclean Medical's unremitting efforts over the years. In the future, Singclean Medical will continue to be committed to the innovation and development of medical technology, make greater contributions to protecting people's health, and help China's medical industry move to new heights.
-
singclean | 2024-04-25
Headlining FIGO 2025: A Can’t-Miss Keynote by Prof. Osama Shawki, Presented by Singclean & KSMSingclean, in partnership with Kayan Al-Seha Medical (KSM), will debut at FIGO 2025 in Cape Town with a keynote lecture by renowned gynecologist Professor Osama Shawki. His session will spotlight innovations in hysteroscopy and adhesion prevention, showcasing Singclean’s commitment to advancing women’s healthcare worldwide. -
singclean | 2024-04-25
Singclean Draws Major Attention at ESCRS 2025 with Advanced Viscoelastic Solution for Ophthalmic SurgeryCOPENHAGEN, DENMARK – Hangzhou Singclean Medical Products Co., Ltd. made a strong impression at the 45th ESCRS Congress (European Society of Cataract and Refractive Surgeons), held September 12–16, 2025, at the Bella Center in Copenhagen. Recognized globally for its high professional standards and influence in ophthalmology, the congress gathered leading industry manufacturers, surgeons, and specialists from around the world. -
singclean | 2024-04-25
Singderm Filler Achieves 92.7% Efficacy at 12 Months in Global Clinical Trial, Validated by Landmark Thailand MasterclassBangkok, Thailand – Singderm, a globally certified dermal filler brand, has demonstrated unprecedented clinical performance in its Thailand Masterclass led by renowned physician Dr. Worawat Nolah. Three top KOLs (Hack Anantaya, Chalidaorn PinNy, Thantaya Thuranuch) received multi-zone injections with zero complications, reinforcing Singderm’s 92.7% 12-month efficacy rate from a 100-subject clinical trial.
